Dermatology Devices Global Market Report 2024 by The Business Research Company | Cutera Inc., Lumenis Ltd., Alma Lasers Ltd., Solta Medical Inc., Aesthetic Group, Ambicare Health Ltd., Image Derm Inc., Johnson & Johnson Private Limited, AMD Global Telemed

The dermatology devices market size has grown rapidly in recent years. It will grow from $14.06 billion in 2023 to $16.33 billion in 2024 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to increased skin health awareness, dermatological conditions prevalence, aging population, increased aesthetic and cosmetic procedures, and skin cancer diagnostics.

The dermatology devices market size is expected to see rapid growth in the next few years. It will grow to $28.84 billion in 2028 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to minimally invasive treatments, rising medical tourism, emerging market growth, and increasing research and development activities. Major trends in the forecast period include adoption of tele-dermatology services, ai and machine learning applications, personalized dermatology care, advanced laser technologies, and dermatology innovation.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=6435&type=smp

Dermatology Devices Market Major Segments
The dermatology devices market covered in this report is segmented -

1) By Product Type: Diagnostic Devices, Treatment Devices, Other Product Types
2) By Application: Skin Cancer Diagnosis, Psoriasis, Skin Rejuvenation, Warts, Other Applications
3)By End User: Hospitals: Clinics, Other End Users

Key Driver - Skin Health Matters Fueling Growth In The Dermatology Devices Market

The increasing prevalence of skin cancer and other skin diseases is expected to propel the growth of the dermatology devices market going forward. Skin cancer is the uncontrolled proliferation of abnormal cells in the epidermis, the outermost layer of the skin. It is caused by malignant tumors formed from unrepaired DNA damage. Other skin-related diseases include eczema, cold sores, dry skin, acne, and others. In order to remove skin tumors, dermatological devices such as light treatment devices, lasers, and electrosurgical equipment are used. For instance, according to the American Cancer Society, a US-based voluntary health organization, in 2022, around 99,780 new melanoma skin cancer cases were diagnosed and around 7,650 patients died due to melanoma, in the US. Therefore, the growing prevalence of skin cancer and other skin diseases is driving the growth of the dermatology devices market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=6435&type=smp

Prominent Trend - Technological Innovations And Ai-Driven Solutions In Skin Cancer Detection

Technological advancements have emerged as a key trend gaining popularity in the dermatology device market. Major companies operating in the dermatology devices sector are focused on new technological innovations to sustain their position in the market. For instance, 3Derm Systems, Inc., a US-based company that manufactures dermatology devices, launched 3DermSpot. The 3DermSpot is an algorithm designed to use artificial intelligence (AI) and highly standardized skin images to help in autonomously detecting melanoma, squamous cell carcinoma, and basal cell carcinoma. This helps in the speedy detection of skin cancer.

Dermatology Devices Market Players
Major companies operating in the dermatology devices market include Cutera Inc., Lumenis Ltd., Alma Lasers Ltd., Solta Medical Inc., Aesthetic Group, Ambicare Health Ltd., Image Derm Inc., Johnson & Johnson Private Limited, AMD Global Telemedicine Inc., Cortex Technology ApS, HEINE Optotechnik GmbH & Co. KG, Michelson Diagnostics Ltd., Bruker Corporation, Bovie Medical Corporation, Illuco Corporation Ltd., Photomedex Inc., Applisonix Ltd., Candela Medical Corporation, STRATA Skin Sciences Inc., WON TECH Co. Ltd., LUSTRE® ClearSkin Ltd., DermLite LLC, Genesis Biosystems Inc., Cynosure LLC, Canfield Scientific Inc., Bausch Health Companies Inc., Stiefel Laboratories, Sun Pharmaceutical Industries Limited, L'Oreal S.A., Galderma S.A., Merz Pharma GmbH & Co. KGaA, Allergan plc, Syneron Medical Ltd., Bio-Therapeutic Inc., Sciton Inc., Viora Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/dermatology-devices-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the dermatology devices market in 2023. Asia-Pacific is the second largest region in the dermatology devices market. The regions covered in the dermatology devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Dermatology Devices Market Report Structure
3. Dermatology Devices Market Trends And Strategies
4. Dermatology Devices Market - Macro Economic Scenario
5. Dermatology Devices Market Size And Growth
…..
27. Dermatology Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.